H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves

ABSTRACT Highly pathogenic avian influenza (HPAI) clade 2.3.4.4b H5N1 circulated widely in lactating dairy cows in the United States following the initial detection in 2024. Due to the critical need for intervention strategies for this outbreak, we evaluated antibody and cellular immune responses of a clade 2.3.4.4b H5 mRNA-LNP vaccine in calves. We found that the H5 mRNA-LNP vaccine induced a robust antibody and CD8 + T cell-mediated immune response and conferred protection against clade 2.3.4.4b H5N1 infection. IMPORTANCE It is important to develop vaccines that limit clade 2.3.4.4b H5N1 infection in cattle. In this study, we found that a new H5 mRNA-lipid nanoparticle vaccine is immunogenic when delivered intramuscularly to male Holstein calves.

Authors

Institutions

Publication Details

Journal
Journal of Virology
Published
2026-10-08
DOI
https://doi.org/10.1128/jvi.01289-26
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves

Naiqing Ye, Bailey L. Arruda, Mitchell V. Palmer, Carine K. Souza et al.
Journal of Virology
Influenza Virus Research Studies
article

H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves

Naiqing Ye, Bailey L. Arruda, Mitchell V. Palmer, Carine K. Souza, Jiaojiao Liu, Paola Mercedes Boggiatto, Scott E. Hensley, Jefferson José da Silva Santos, Amy L. Vincent Baker, Alessandra Campos, Haley M. Sterle, Drew Weissmann
article en

Abstract

ABSTRACT Highly pathogenic avian influenza (HPAI) clade 2.3.4.4b H5N1 circulated widely in lactating dairy cows in the United States following the initial detection in 2024. Due to the critical need for intervention strategies for this outbreak, we evaluated antibody and cellular immune responses of a clade 2.3.4.4b H5 mRNA-LNP vaccine in calves. We found that the H5 mRNA-LNP vaccine induced a robust antibody and CD8 + T cell-mediated immune response and conferred protection against clade 2.3.4.4b H5N1 infection. IMPORTANCE It is important to develop vaccines that limit clade 2.3.4.4b H5N1 infection in cattle. In this study, we found that a new H5 mRNA-lipid nanoparticle vaccine is immunogenic when delivered intramuscularly to male Holstein calves.

Journal of Virology
National Animal Disease Center (US), University of Pennsylvania (US)
Openalex Percentile: Top 11%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves — Naiqing Ye, Bailey L. Arruda, et al. · Journal of Virology (2026) | TGRS Research Map | TGRS